Literature DB >> 15367704

Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2.

Christine Syng-Ai1, A Leela Kumari, Ashok Khar.   

Abstract

Curcumin, a well-known dietary pigment derived from Curcuma longa, inhibited growth of several types of malignant cells both in vivo and in vitro. However, its mechanism of action still remains unclear. In this study, we have focused primarily on the cytotoxic effects of curcumin on three human tumor cell lines and rat primary hepatocytes. Curcumin induced apoptosis in MCF-7, MDAMB, and HepG2 cells in a dose-dependent and time-dependent manner. Apoptosis was mediated through the generation of reactive oxygen species. Attempts were made to establish the role played by endogenous glutathione on the apoptotic activity of curcumin. Depletion of glutathione by buthionine sulfoximine resulted in the increased generation of reactive oxygen species, thereby further sensitizing the cells to curcumin. Interestingly, curcumin had no effect on normal rat hepatocytes, which showed no superoxide generation and therefore no cell death. These observations suggest that curcumin, a molecule with varied actions, could be developed into an effective chemopreventive and chemotherapeutic agent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15367704

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  98 in total

1.  Curcumin prevents leptin raising glucose levels in hepatic stellate cells by blocking translocation of glucose transporter-4 and increasing glucokinase.

Authors:  Youcai Tang; Anping Chen
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

2.  14-Deoxy-11,12-didehydroandrographolide inhibits proliferation and induces GSH-dependent cell death of human promonocytic leukemic cells.

Authors:  Rahul Raghavan; Sanith Cheriyamundath; Joseph Madassery
Journal:  J Nat Med       Date:  2014-01-24       Impact factor: 2.343

3.  Clinical comparison of dose calculation using the enhanced collapsed cone algorithm vs. a new Monte Carlo algorithm.

Authors:  Irina Fotina; Gabriele Kragl; Bernhard Kroupa; Robert Trausmuth; Dietmar Georg
Journal:  Strahlenther Onkol       Date:  2011-06-27       Impact factor: 3.621

4.  Encapsulation of curcumin in self-assembling peptide hydrogels as injectable drug delivery vehicles.

Authors:  Aysegul Altunbas; Seung J Lee; Sigrid A Rajasekaran; Joel P Schneider; Darrin J Pochan
Journal:  Biomaterials       Date:  2011-05-23       Impact factor: 12.479

5.  Localization and dynamics of the anticarcinogenic curcumin with GM1 and other miceller assemblies.

Authors:  Malay Patra; Manoj Mandal; Abhijit Chakrabarti; Chaitali Mukhopadhyay
Journal:  Glycoconj J       Date:  2016-11-19       Impact factor: 2.916

6.  In vitro study of the cytotoxicity of thymoquinone/curcumin fluorescent liposomes.

Authors:  Heba Mohamed Fahmy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-03       Impact factor: 3.000

7.  Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells.

Authors:  Matthew Miller; Shenglin Chen; Jeffrey Woodliff; Sanjay Kansra
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

8.  Curcumin attenuates the effects of insulin on stimulating hepatic stellate cell activation by interrupting insulin signaling and attenuating oxidative stress.

Authors:  Jianguo Lin; Shizhong Zheng; Anping Chen
Journal:  Lab Invest       Date:  2009-10-19       Impact factor: 5.662

9.  Growth suppression of mouse pituitary corticotroph tumor AtT20 cells by curcumin: a model for treating Cushing's disease.

Authors:  Madhavi Latha Yadav Bangaru; Jeffrey Woodliff; Hershel Raff; Sanjay Kansra
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

10.  Curcumin induces apoptosis-independent death in oesophageal cancer cells.

Authors:  G O'Sullivan-Coyne; G C O'Sullivan; T R O'Donovan; K Piwocka; S L McKenna
Journal:  Br J Cancer       Date:  2009-10-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.